Alyftrek (vanzacaftor–tezacaftor–deutivacaftor), made by Vertex, represents the latest advance in CFTR modulator treatments that are transforming cystic fibrosis care by targeting the underlying cause ...

Access to a range of journals, databases and other evidence-based resources for health and social care staff in England.

The 10-Year Health Plan marks a significant step forward in building an NHS that is faster, fairer and fit for the future. At NICE, we’re ready to deliver - using our expanded remit to accelerate ...

Subscribe to our newsletters, alerts and awareness service. Keep up to date with the latest evidence based information across health and social care.

The new approach will ensure that high-impact devices, diagnostics and digital tools recommended by NICE, that meet the most urgent needs, are nationally reimbursed and made available across the NHS - ...

Discussing medicines support Make sure medicines support is considered when assessing a person’s needs, consulting with healthcare colleagues if necessary. Talk to the person and (if they agree) their ...

We're looking for health, social care and other professionals and practitioners to take an active role in producing a NICE guideline or quality standard.